Celldex Therapeutics, Inc.
CLDX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $1.54M | $7.02M | −78.1% |
| Operating income | −$287M | −$195M | −47.3% |
| Net income | −$259M | −$158M | −63.9% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $0K | $0K | |
| Operating income | −$82.3M | −$73.6M | −11.8% |
| Net income | −$75.6M | −$67.0M | −12.8% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Celldex's revenue in FY2025?
- $1.54M in FY2025 (Fiscal year ended Dec 31, 2025), −78.1% vs $7.02M a year earlier, per its 10-K filed Feb 2026.
- Was Celldex profitable in FY2025?
- No: net income was −$259M and operating income −$287M in FY2025.
- What was Celldex's revenue in Q3 2026?
- $0K (n/a vs a year earlier), per its Form 10-Q filed Nov 5, 2026.